Impact of Dose‐Escalation Design on the Safety and Development of Anticancer Drugs in Clinical Trials

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	Clinical and Translational Science vol. 18, no. 10 (Oct 1, 2025)
Kaituhi matua:	Nonami, Atsushi
Ētahi atu kaituhi:	Matsuda, Kensuke, Funakoshi, Kouta, Kato, Ryosuke, Takahashi, Hideaki, Edahiro, Yoko
I whakaputaina:	John Wiley & Sons, Inc.
Ngā marau:	Japan Cancer Enrollments Clinical trials Monoclonal antibodies Simulation Computers Toxicity Regression analysis Pharmacodynamics Medical equipment Cytotoxicity Pharmaceuticals Regulatory approval Antineoplastic drugs Variables Drug development Statistical analysis Patients Hematology Drug dosages
Urunga tuihono:	Citation/Abstract Full Text Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Me noho koe te mea tuatahi ki te waiho tākupu!